MedAssets VP of Business Development Salaries in Seattle | Comparably
A publicly traded American company read more
EMPLOYEE
PARTICIPANTS
5
TOTAL
RATINGS
77

MedAssets VP of Business Development Salaries in Seattle

The average MedAssets VP of Business Development in Seattle earns an estimated $183,569 annually. MedAssets' VP of Business Development compensation is $27,533 less than the US average for a VP of Business Development.

In Seattle, The Business Development Department at MedAssets earns $36 more on average than the Marketing Department.

Last updated 7 years ago.

$37k
$90k
$145k
$200k
$410k
$824k
$183,569
Average Compensation
$183,569
avg. base

VP of Business Development Salaries at MedAssets

In Seattle, VPs of Business Development earn $64,066 more than Business Development Managers.

Business Development Manager
$120k*
Account Executive
$83k*
Account Manager
$83k*
* estimated salary

Compensation at MedAssets by Department

In Seattle, The Business Development Department averages $36 more than the Marketing Department, and $11,498 less than the Finance Department

Finance
$88,026 Avg. total comp.
+$11k
Business Development
$76,528 Avg. total comp.
Marketing
$76,492 Avg. total comp.
-$36

VP of Business Development Compensation by Gender (All Companies)

The average female VP of Business Development at companies similar size to MedAssets reported making $289,257, while the average male VP of Business Development at similar sized companies reported making $251,458.

VP of Business Development Compensation by Ethnicity (All Companies)

The average Caucasian VP of Business Development at companies similar size to MedAssets reported making $263,559, while the average Hispanic or Latino VP of Business Development at similar sized companies reported making $220,000.

How VPs of Business Development at MedAssets Rate Their Compensation

The majority of VPs of Business Development at MedAssets believe they're compensated fairly. 100% of VPs of Business Development at MedAssets say they receive annual bonuses, and the vast majority (25%) are not satisfied with their benefits. See more compensation ratings at MedAssets

×
Rate your company